208 related articles for article (PubMed ID: 33809700)
21. Transferrin-Decorated Niosomes with Integrated InP/ZnS Quantum Dots and Magnetic Iron Oxide Nanoparticles: Dual Targeting and Imaging of Glioma.
Ag Seleci D; Maurer V; Barlas FB; Porsiel JC; Temel B; Ceylan E; Timur S; Stahl F; Scheper T; Garnweitner G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925347
[TBL] [Abstract][Full Text] [Related]
22. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
23. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy.
Saw PE; Yao H; Lin C; Tao W; Farokhzad OC; Xu X
Nano Lett; 2019 Sep; 19(9):5967-5974. PubMed ID: 31381852
[TBL] [Abstract][Full Text] [Related]
24. Poly(
Yang Y; Kozlovskaya V; Zhang Z; Xing C; Zaharias S; Dolmat M; Qian S; Zhang J; Warram JM; Yang ES; Kharlampieva E
ACS Appl Bio Mater; 2022 Apr; 5(4):1670-1682. PubMed ID: 35294185
[TBL] [Abstract][Full Text] [Related]
25. The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Akbarzadeh I; Farid M; Javidfar M; Zabet N; Shokoohian B; Arki MK; Shpichka A; Noorbazargan H; Aghdaei HA; Hossein-Khannazer N; Timashev P; Makvandi P; Vosough M
AAPS PharmSciTech; 2022 Jan; 23(1):57. PubMed ID: 35048234
[TBL] [Abstract][Full Text] [Related]
26. Brij Niosomes as Carriers for Sustained Drug Delivery─A Fluorescence-Based Approach to Probe the Niosomal Microenvironment.
Sarkar S; De S
Langmuir; 2022 Apr; 38(15):4521-4537. PubMed ID: 35377656
[TBL] [Abstract][Full Text] [Related]
27. Formulation, optimization and evaluation of amisulpride-loaded niosomal intranasal gel for brain targeting.
Patil VS; Sutar KP; Pockle RD; Usulkar S; Jadhav VA
Ther Deliv; 2023 Oct; 14(10):635-647. PubMed ID: 38050965
[TBL] [Abstract][Full Text] [Related]
28. Co-delivery of cisplatin and siRNA through hybrid nanocarrier platform for masking resistance to chemotherapy in lung cancer.
Patel V; Lalani R; Vhora I; Bardoliwala D; Patel A; Ghosh S; Misra A
Drug Deliv Transl Res; 2021 Oct; 11(5):2052-2071. PubMed ID: 33174096
[TBL] [Abstract][Full Text] [Related]
29. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Gandhi NS; Tekade RK; Chougule MB
J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
[TBL] [Abstract][Full Text] [Related]
30. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
[TBL] [Abstract][Full Text] [Related]
31. siRNA and targeted delivery systems in breast cancer therapy.
Mirzaei S; Paskeh MDA; Entezari M; Bidooki SH; Ghaleh VJ; Rezaei S; Hejazi ES; Kakavand A; Behroozaghdam M; Movafagh A; Taheriazam A; Hashemi M; Samarghandian S
Clin Transl Oncol; 2023 May; 25(5):1167-1188. PubMed ID: 36562927
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.
Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN
J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511
[TBL] [Abstract][Full Text] [Related]
33. Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells.
Palanca-Wessels MC; Booth GC; Convertine AJ; Lundy BB; Berguig GY; Press MF; Stayton PS; Press OW
Oncotarget; 2016 Feb; 7(8):9561-75. PubMed ID: 26840082
[TBL] [Abstract][Full Text] [Related]
34. Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment.
Basheer HA; Alhusban MA; Zaid Alkilani A; Alshishani A; Elsalem L; Afarinkia K
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894371
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications.
Abosalha AK; Ahmad W; Boyajian J; Islam P; Ghebretatios M; Schaly S; Thareja R; Arora K; Prakash S
Expert Opin Drug Discov; 2023 Feb; 18(2):149-161. PubMed ID: 36514963
[TBL] [Abstract][Full Text] [Related]
36. Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro.
Wu Z; Xu XL; Zhang JZ; Mao XH; Xie MW; Cheng ZL; Lu LJ; Duan XH; Zhang LM; Shen J
Nanomaterials (Basel); 2017 May; 7(5):. PubMed ID: 28492491
[TBL] [Abstract][Full Text] [Related]
37. Proof of concept studies for siRNA delivery by nonionic surfactant vesicles:
Obeid MA; Dufès C; Somani S; Mullen AB; Tate RJ; Ferro VA
J Liposome Res; 2019 Sep; 29(3):229-238. PubMed ID: 30296860
[TBL] [Abstract][Full Text] [Related]
38. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
[TBL] [Abstract][Full Text] [Related]
39. Development of a T Cell-targeted siRNA Delivery System Against HIV-1 Using Modified Superparamagnetic Iron Oxide Nanoparticles: An In Vitro Study.
Kamalzare S; Iranpur Mobarakeh V; Mirzazadeh Tekie FS; Hajiramezanali M; Riazi-Rad F; Yoosefi S; Normohammadi Z; Irani S; Tavakoli M; Rahimi P; Atyabi F
J Pharm Sci; 2022 May; 111(5):1463-1469. PubMed ID: 34673092
[TBL] [Abstract][Full Text] [Related]
40. Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.
Merckx P; De Backer L; Van Hoecke L; Guagliardo R; Echaide M; Baatsen P; Olmeda B; Saelens X; Pérez-Gil J; De Smedt SC; Raemdonck K
Acta Biomater; 2018 Sep; 78():236-246. PubMed ID: 30118853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
